Intestinal Fistulas Workup
- Author: David E Stein, MD; Chief Editor: Julian Katz, MD more...
Albumin and prealbumin levels should be obtained, as well as blood urea nitrogen (BUN), creatinine, and electrolyte concentrations. These are used to determine the patient's nutritional status and whether fluid or metabolic disturbances are present (more of a concern for high-output fistulas).
Although complete blood count (CBC) results may be within the reference range, leukocytosis may be present if an undrained abscess or a continued inflammatory process has developed within a segment of the bowel. Anemia may be present with chronic disease or if a malignant process is involved.
Abscess culture findings may be helpful, especially in the presence of sepsis or ongoing infection (the predominant organism involved being Escherichia coli). Cultures of enterocutaneous fistula output may not be of much clinical use, as normal bowel flora often predominates.
Urinalysis or urine culture
For colovesical fistulas, urinalysis usually reveals increased white blood cell (WBC) count and bacteria levels. Urine culture findings may help to direct antibiotic therapy.
Histologic findings of fistula site biopsy are usually consistent with chronic inflammation. In patients with Crohn disease as the causative factor, transmural involvement with noncaseating granulomas and lymphoid aggregates throughout the bowel wall may be observed. In patients with carcinoma, inflammation adjacent to the tumor remains a typical finding. The clinical scenario and test results are usually helpful in determining the diagnosis.
Staging is appropriate when the etiology of the fistula is carcinoma.
Oral administration of nonabsorbable markers
Patients can be given charcoal or Congo red dye orally to verify the presence of an enterocutaneous fistula. However, this is not helpful in determining which portion of bowel is involved. This test is often used in postoperative patients with persistent drainage from a wound in whom an enterocutaneous fistula is suspected or in women with persistent vaginal drainage in whom a rectovaginal fistula is suspected.
Endoscopy or colonoscopy
This can be helpful in determining the origin of the bowel disease that caused the fistula, but it is not a particularly helpful or necessary study to reveal a fistula. Biopsy samples may be obtained during the procedure and are useful in diagnosing IBD or Crohn disease and malignancy.
Although it has been reported and described, this procedure is not a widely used modality for diagnostic and therapeutic use with enteric fistulas. A small-caliber endoscope is passed into the lumen of the fistula in an attempt to identify the source of the fistula. Fistuloscopy may identify abscesses and visualize the bowel involved. Therapeutically, a drain can be placed or fibrin glue sealant may be applied to close the fistula.
Useful in the evaluation of suspected enterovesical fistula, cystoscopy may allow visualization of fistulas from within the bladder.
Instilling methylene blue into the rectum and examining a vaginal tampon 15 minutes after placement can often establish the presence of a rectovaginal fistula.
Abdominal and pelvic computed tomography (CT) scanning is the imaging method of choice to evaluate Crohn disease and possible fistulas. While identification of the fistula is not always possible, CT scanning often reveals perifistular inflammation. This provides additional information regarding the possible etiology of the fistula and the extraluminal involvement of disease.
Revealing abscess cavities or excluding possible sources of sepsis is an important step in the evaluation of patients with suspected fistulas. This information may also prove helpful if surgical intervention is planned. CT angiography may be used in the diagnosis of suspected aortoenteric fistulas if the patient is stable.
Although magnetic resonance imaging (MRI) is reported as an imaging modality that can help identify and characterize enteric fistulas, motion artifact may limit its usefulness, and MRI is not considered a routine adjunctive study in the evaluation of patients with enteric fistulas. T1-weighted images provide information relative to the inflammation in fat planes and possible extension of the fistula relative to the surrounding visceral structures. T2-weighted images can demonstrate fluid collections along the fistula tract and inflammatory changes within the surrounding muscle.
Radiographic study with contrast medium (usually given at the site of fistula output) may be performed to help delineate the extent of the fistula and its communication with the underlying bowel.
Ultrasonography can be used in conjunction with physical examination to identify abscesses and fluid collections along the fistula tract.
Barium enema and small bowel series
Contrast studies to evaluate the stomach, small intestine, and colon may reveal a fistula and may also be helpful in determining the cause of fistula formation by identifying diverticular disease, Crohn disease (characteristic string sign), or evidence of malignancy.
Cystography and CT cystography
This procedure can help to evaluate for the presence of a possible enterovesical fistula.
Angiography may assist in preoperative planning and evaluation of aortoenteric fistulas in a stable patient or determine the arterial source of bleeding in those with a less common arterioenteric fistula.
Elliott TB, Yego S, Irvin TT. Five-year audit of the acute complications of diverticular disease. Br J Surg. 1997 Apr. 84(4):535-9. [Medline].
Berry SM, Fischer JE. Classification and pathophysiology of enterocutaneous fistulas. Surg Clin North Am. 1996 Oct. 76(5):1009-18. [Medline].
Kyle J, Lee ECG, Nolan DJ. Fistulae in Crohn’s Disease. Clinical Surgery International: Surgery of Inflammatory Bowel Disorders. 1987. Vol 14:190-6.
Annibali R, Pietri P. Fistulous complications of Crohn's disease. Int Surg. 1992 Jan-Mar. 77(1):19-27. [Medline].
Lavery IC. Colonic fistulas. Surg Clin North Am. 1996 Oct. 76(5):1183-90. [Medline].
Donner CS. Pathophysiology and therapy of chronic radiation-induced injury to the colon. Dig Dis. 1998 Jul-Aug. 16(4):253-61. [Medline].
Böttger TC, Junginger T. Factors influencing morbidity and mortality after pancreaticoduodenectomy: critical analysis of 221 resections. World J Surg. 1999 Feb. 23(2):164-71; discussion 171-2. [Medline].
Falconi M, Pederzoli P. The relevance of gastrointestinal fistulae in clinical practice: a review. Gut. 2001 Dec. 49 Suppl 4:iv2-10. [Medline].
Pontari MA, McMillen MA, Garvey RH, et al. Diagnosis and treatment of enterovesical fistulae. Am Surg. 1992 Apr. 58(4):258-63. [Medline].
Rots WI, Mokoena T. Successful endoscopic closure of a benign gastrocolonic fistula using human fibrin sealant through gastroscopic approach: a case report and review of the literature. Eur J Gastroenterol Hepatol. 2003 Dec. 15(12):1351-6. [Medline].
Hancock BD. ABC of colorectal diseases. Haemorrhoids. BMJ. 1992 Apr 18. 304(6833):1042-4. [Medline].
Rolandelli R, Roslyn JJ. Surgical management and treatment of sepsis associated with gastrointestinal fistulas. Surg Clin North Am. 1996 Oct. 76(5):1111-22. [Medline].
Pederzoli P, Bassi C, Falconi M, et al. Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin. Surg Gynecol Obstet. 1986 Nov. 163(5):428-32. [Medline].
Wedell J, Banzhaf G, Chaoui R, et al. Surgical management of complicated colonic diverticulitis. Br J Surg. 1997 Mar. 84(3):380-3. [Medline].
Levy C, Tremaine WJ. Management of internal fistulas in Crohn's disease. Inflamm Bowel Dis. 2002 Mar. 8(2):106-11. [Medline].
Goverman J, Yelon JA, Platz JJ, et al. The "Fistula VAC," a technique for management of enterocutaneous fistulae arising within the open abdomen: report of 5 cases. J Trauma. 2006 Feb. 60(2):428-31; discussion 431. [Medline].
Dorta G. Role of octreotide and somatostatin in the treatment of intestinal fistulae. Digestion. 1999. 60 Suppl 2:53-6. [Medline].
Rahbour G, Siddiqui MR, Ullah MR, et al. A meta-analysis of outcomes following use of somatostatin and its analogues for the management of enterocutaneous fistulas. Ann Surg. 2012 Dec. 256(6):946-54. [Medline].
Amiot A, Setakhr V, Seksik P, et al. Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID. Am J Gastroenterol. 2014 Sep. 109(9):1443-9. [Medline].
Greenstein AJ. The surgery of Crohn's disease. Surg Clin North Am. 1987 Jun. 67(3):573-96. [Medline].
Von Koperen PJ, Bemelman WA, Gerhards MF, Janssen LW, van Tets WF, van Dalsen AD, et al. The anal fistual plug treatment compared with the mucosal advancement flap for cryptoglandular high transsphincteric perianal fistula: a double-blinded multicenter randomized trial. Dis Colon Rectum. Apr 2011. 54(4):387-93. [Medline].
Butchberg B, Masoomi H, Choi J, Bergman H, Mills S, Stamos MJ. A tale of two (anal fistula) plugs: is there a difference in short-term outcomes?. Am Surg. Oct 2010. 76(10):1150-3. [Medline].
Zhu YF, Tao GQ, Zhou N, Xiang C. Current treatment of rectovaginal fistula in Crohn's disease. World J Gastroenterol. Feb 2011. 17(8):963f-7. [Medline].
Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999 May 6. 340(18):1398-405. [Medline].
Ellis CN. Sphincter-preserving fistula management: what patients want. Dis Colon Rectum. Dec 2010. (53(12):1652-5. [Medline].
Lindberg E, Jarnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut. 1992 Jun. 33(6):779-82. [Medline].
Meissner K. Late radiogenic small bowel damage: guidelines for the general surgeon. Dig Surg. 1999. 16(3):169-74. [Medline].
Practice parameters for treatment of fistula-in-ano--supporting documentation. The Standards Practice Task Force. The American Society of Colon and Rectal Surgeons. Dis Colon Rectum. 1996 Dec. 39(12):1363-72. [Medline].
Schecter WP. Management of enterocutaneous fistulas. Surg Clin North Am. Jun 2011. 91(3):481-91. [Medline].